采用小鼠被动免疫模型评估重组保护性抗原疫苗(GC1109)免疫人血清的保护效力
研究从接种新型重组保护性抗原炭疽疫苗(GC1109)者中按毒素中和试验(TNA)滴度(ED50 55至668)选取18份人血清,稀释后被动转移至A/J小鼠,再用100×LD50炭疽芽孢杆菌Sterne株芽孢攻击;被动免疫小鼠存活率与转移血清TNA ED50相关(r=0.873,P<0.001),对致死攻击50%存活率所需TNA滴度为197(95%CI 149至260),提示GC1109具有保护作用且TNA滴度可作为保护效力指标。
要点
- 18份接种者血清按TNA ED50 55至668选取,被动转移后以100×LD50 Sterne株芽孢攻击小鼠。
- 被动免疫小鼠存活率与转移血清TNA ED50相关(r=0.873,P<0.001)。
- 对致死攻击50%存活率所需TNA滴度估计为197(95%CI 149至260)。
核心结论
- 结果提示GC1109对炭疽芽孢杆菌暴露具有保护作用,且接种者血清TNA滴度可作为保护效力的指标。
研究设计与样本
- 从接种新型重组保护性抗原炭疽疫苗(GC1109)者中按TNA滴度(ED50 55至668)选取18份人血清,稀释后被动转移至A/J小鼠,随后以100×LD50炭疽芽孢杆菌Sterne株芽孢攻击。
主要发现
- 被动免疫小鼠存活率与转移血清TNA ED50相关(r=0.873,P<0.001)。
- 对致死攻击50%存活率所需TNA滴度估计为197(95%CI 149至260)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The protective efficacy of human sera from vaccinated individuals with a new recombinant protective antigen anthrax vaccine (GC1109) against lethal spore challenge was evaluated in a mouse model. Eighteen human sera were selected from the vaccinated individuals based on their toxin neutralizing assay (TNA) titer (ED50 of 55 to 668). The selected sera were diluted and passively transferred to A/J mice and the mice were subsequently challenged with 100 × LD50 of Bacillus anthracis Sterne spores. The correlation between the survival rate of passively immunized mice and the TNA ED50 of transferred sera was presented (r = 0.873, P-value < 0.001). The estimated TNA titer for 50% survival rate against lethal challenge was 197 (95% confidence interval of 149 and 260). The result suggest that GC1109 is protective against exposure to B. anthracis and the TNA titer of vaccinated serum can be an indicator for protective efficacy.
引用
- Jo SK, Ahn BE, Choi EH, et al. Evaluation of the protective efficacy of recombinant protective antigen vaccine (GC1109)-immunized human sera using passive immunization in a mouse model. Vaccine. 2020. PMID: 31911031. doi:10.1016/j.vaccine.2019.12.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。